Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.57 |
| ▸ | NPY1R | P25929 | 9/20 | 0.57 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.57 |
| ▸ | NPY2R | P49146 | 5/20 | 0.57 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9751974 | 1.00 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30688833 | 0.95 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31679470 | 0.94 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31184580 | 0.91 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31184390 | 0.91 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31679394 | 0.91 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29637467 | 0.90 | NPY4R (0.66) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30089376 | 0.90 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30450301 | 0.90 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL3217302 | 0.90 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0454782-A1 | CANCER RELATED HAPTOGLOBIN (HPR). | UNIV JOHNS HOPKINS (US) | 1991-11-06 | — | — | EP | disclosed |
| WO-1990008324-A1 | CANCER RELATED HAPTOGLOBIN (HPR) | THE JOHNS HOPKINS UNIVERSITY (US) | 1990-07-26 | — | — | WO | disclosed |